CASI CASI Pharmaceuticals Inc.: Bathi resik saben siji saham sajrone rolas wulan pungkasan

The operating cash flow of CASI Pharmaceuticals (CASI) is supported by the sale of approved oncology drugs in China, as confirmed by the EPS YoY TTM dynamics, where the metric level stands at -42.10. Financial stability is based on the commercialization of licenses and the expansion of the product pipeline. Business development relies on a cross-cultural synthesis of US and Asian science, attracting specialists through large-scale investments in innovative research.

CASI Pharmaceuticals Inc. (CASI): Bathi resik saben saham (EPS TTM) saka 11.02.2024 nganti 14.03.2026

CASI Pharmaceuticals - rincian analitis lan metrik utama (CASI)

- rega saham lan prakiraan rega para ahli:

Bagan rega CASI Pharmaceuticals, Inc.|CASI - Bagan rega target

- data kapitalisasi saham perusahaan:

Nilai pasar CASI Pharmaceuticals, Inc|CASI - Nilai Total Perusahaan

- rincian nilai buku perusahaan:

Nilai Aset Bersih saben Saham CASI Pharmaceuticals|CASI - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku casipharmaceuticals.com|CASI - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas CASI Pharmaceuticals|CASI - Utang jangka dawa marang modal|Utang jangka cendhak marang modal CASI Pharmaceuticals, Inc.|CASI - Utang perusahaan|Utang-utang marang aset resik CASI|CASI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak CASI Pharmaceuticals|Rasio jangkoan perantara casipharmaceuticals.com

- data bathi resik lan rasio valuasi:

CASI - Bathi resik perusahaan|Bathi forward CASI Pharmaceuticals|CASI - Pangali P/E|Pangali mangsa ngarep rega marang bathi casipharmaceuticals.com|CASI - Pangali PEG|Pangali EV/EBITDA CASI Pharmaceuticals, Inc|CASI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku CASI Pharmaceuticals|CASI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan casipharmaceuticals.com|CASI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep CASI Pharmaceuticals

- indikator dodolan lan pendapatan:

CASI - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan casipharmaceuticals.com|CASI - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CASI Pharmaceuticals

Analisis wiwitan perusahaan:CASI (CASI Pharmaceuticals Inc.)

Produk asil prodhuksi CASI Pharmaceuticals, Inc

This indicator measures the annual growth rate of net income per share over a rolling 12-month period, identifying deviations in operational efficiency from historical trends. By analyzing the 12-month EPS YoY history, an investor can assess how the commercialization of oncology drugs in the Chinese market converts into real shareholder returns for CASI Pharmaceuticals (CASI), separating systemic growth from one-time accounting adjustments.

Analisis pesaing CASI Pharmaceuticals